WebMD expands its scope with Qualcomm partnership

Share this article:
WebMD expands its scope with Qualcomm partnership
WebMD expands its scope with Qualcomm partnership

WebMD is getting personal. That's the upshot of the portal's latest venture, an alliance with QualcommLife.

The collaboration puts WebMD on track to create devices that tap into Qualcomm's FDA-approved Life 2Net Platform, ones capable of storing personal information and syncing data clouds with other 2Net Platform users such as activity tracker FitBit. WebMD chief technology officer William Pence told MM&M the deal gives WebMD the latitude to help multi-brand device users keep what they've got and build from there.

It would also allow WebMD, which has been struggling to hang onto ad revenue and fend off competitors like Everyday Health, to better leverage the information millions of profiled users have provided to the site. Pence told MM&M that users are already incorporating the site into daily life by using its apps in locations such as the doctor's office or pharmacy.

Pence said he envisions being able to offer users a suite of supportive devices, such as heart monitors, at no cost. He said the new business will also let the company wrap the data with contextual insights by tapping into existing WebMD content.

Pence noted that the company has an added benefit—a backlog of consumer trust. “People know we're sensitive to the needs of the consumer,” he said.”

The first device will come out this fall and WebMD's first focus will be on consumers. But Pence said the company also wants to ease doctors into accepting devices as tools for patient care.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?